Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Frequency Therapeutics, Inc. (FREQ) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/14/2023 8-K Investor presentation
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Korro Bio and Frequency Therapeutics Announce Merger Agreement",
"Investor Presentation dated July 2023"
12/13/2022 8-K Quarterly results
09/12/2022 8-K Investor presentation
Docs: "Frequency Therapeutics, Inc. Corporate Slide Presentation as of September 12, 2022",
"Frequency Therapeutics, Inc. Corporate Slide Presentation as of September 12, 2022"
04/08/2022 8-K Investor presentation
Docs: "Frequency Therapeutics, Inc. Corporate Slide Presentation as of April 8, 2022",
"Frequency Therapeutics, Inc. Corporate Slide Presentation as of April 8, 2022"
03/18/2022 8-K Investor presentation
Docs: "Frequency Therapeutics, Inc. Corporate Slide Presentation as of March 18, 2022",
"Frequency Therapeutics, Inc. Corporate Slide Presentation as of March 18, 2022"
01/13/2022 8-K Investor presentation
Docs: "Frequency Therapeutics, Inc. Corporate Slide Presentation as of January 13, 2022",
"Frequency Therapeutics, Inc. Corporate Slide Presentation as of January 13, 2022"
12/09/2021 8-K Quarterly results
09/22/2021 8-K Quarterly results
08/12/2021 8-K Investor presentation, Quarterly results
Docs: "Frequency Therapeutics Provides Business Updates and Second Quarter 2021 Financial Results Company Plans to Commence New FX-322 Phase 2 Study in Q4 2021 in a Refined Population of Individuals with Sensorineural Hearing Loss",
"Frequency Therapeutics, Inc. Corporate Slide Presentation as of August 12, 2021"
06/30/2021 8-K Investor presentation
Docs: "Frequency Therapeutics, Inc. Corporate Slide Presentation as of June 30, 2021",
"Frequency Therapeutics, Inc. Corporate Slide Presentation as of June 30, 2021"
03/23/2021 8-K Quarterly results
02/22/2021 8-K Quarterly results
01/11/2021 8-K Quarterly results
10/29/2020 8-K Investor presentation
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : October 29, 2020 FREQUENCY THERAPEUTICS, INC. Delaware 001-39062 47-2324450 19 Presidential Way, 2nd Floor Woburn, MA 01801 389-1970 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 unde...",
"Frequency Therapeutics, Inc. Corporate Slide Presentation as of October 29, 2020",
"FREQUENCY THERAPEUTICS ANNOUNCES EXPANDED FX-322 CLINICAL DEVELOPMENT PROGRAM AND UPCOMING DAY-90 PHASE 2a ANALYSIS"
05/14/2020 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy